You can find the annual or quarterly income statement of Humacyte Inc here for insights into the performance and operational efficiency of Humacyte Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Total revenue

34.88%406.00K

-4.26%495.00K

--467.00K

--753.00K

--301.00K

--517.00K

----

--0.00

-100.00%0.00

-87.14%31.00K

88.55%1.30M

50.32%233.00K

42.74%177.00K

-73.63%241.00K

--690.00K

--155.00K

--124.00K

--914.00K

Revenue

34.88%406.00K

-4.26%495.00K

--467.00K

--753.00K

--301.00K

--517.00K

----

--0.00

-100.00%0.00

-87.14%31.00K

88.55%1.30M

50.32%233.00K

42.74%177.00K

-73.63%241.00K

--690.00K

--155.00K

--124.00K

--914.00K

Cost of revenue

477.93%1.23M

1286.39%2.04M

--9.08M

--260.00K

--213.00K

--147.00K

----

Operating expenses

-8.75%27.40M

24.17%29.43M

11.45%31.30M

-16.84%25.14M

1.79%30.03M

-10.82%23.70M

7.28%28.09M

22.79%30.23M

10.36%29.50M

18.06%26.58M

25.94%26.18M

4.66%24.62M

34.79%26.73M

2.35%22.51M

-4.65%20.79M

13.19%23.52M

-0.64%19.83M

10.40%22.00M

38.03%21.80M

14.66%20.78M

--19.96M

--19.92M

--15.80M

--18.13M

R&D expenses

-17.55%18.14M

26.23%19.46M

-29.29%14.61M

-24.66%17.27M

-7.35%22.01M

-27.49%15.42M

2.36%20.66M

23.58%22.93M

15.64%23.75M

23.07%21.26M

34.92%20.18M

7.01%18.55M

40.19%20.54M

5.91%17.28M

-7.96%14.96M

12.68%17.34M

0.58%14.65M

7.78%16.31M

23.12%16.25M

4.72%15.39M

--14.57M

--15.14M

--13.20M

--14.69M

Depreciation, depletion, and amortization

-3.98%1.79M

-2.29%1.79M

-1.11%1.79M

2.92%1.86M

4.55%1.86M

2.29%1.83M

-1.36%1.81M

-0.98%1.81M

-10.29%1.78M

-13.60%1.79M

-13.29%1.83M

-10.07%1.83M

-1.88%1.98M

1.62%2.07M

3.32%2.11M

-1.17%2.04M

-2.18%2.02M

-1.45%2.04M

-1.49%2.05M

-1.10%2.06M

--2.07M

--2.08M

Operating profit

9.19%-27.00M

-24.81%-28.93M

-9.78%-30.84M

19.33%-24.39M

-0.77%-29.73M

12.77%-23.18M

-7.28%-28.09M

-22.79%-30.23M

-10.36%-29.50M

-18.06%-26.58M

-25.94%-26.18M

-4.80%-24.62M

-44.25%-26.73M

-3.44%-22.51M

3.87%-20.79M

-14.36%-23.49M

3.83%-18.53M

-10.09%-21.76M

-38.00%-21.63M

-19.35%-20.54M

---19.27M

---19.77M

---15.67M

---17.21M

Net non-operating interest income (expenses)

Non-operating interest income

-53.37%388.00K

-50.15%330.00K

-40.96%503.00K

-35.24%590.00K

-36.49%832.00K

-35.79%662.00K

-25.52%852.00K

-33.46%911.00K

-11.43%1.31M

-30.10%1.03M

-19.09%1.14M

55.04%1.37M

391.36%1.48M

4658.06%1.48M

14040.00%1.41M

29333.33%883.00K

14950.00%301.00K

3000.00%31.00K

900.00%10.00K

50.00%3.00K

--2.00K

--1.00K

--2.00K

Non-operating interest expense

-8.80%2.32M

-24.30%2.27M

23.33%3.09M

7.14%2.61M

1.19%2.54M

65.20%3.00M

45.22%2.51M

66.64%2.44M

47.08%2.52M

6.89%1.82M

5.37%1.73M

-10.85%1.46M

14.92%1.71M

18.65%1.70M

17.41%1.64M

36.30%1.64M

22.47%1.49M

168.67%1.43M

158.04%1.40M

119.31%1.20M

--1.22M

--533.00K

--541.00K

--549.00K

Special income (expenses)

-26.62%-7.87M

-79.50%13.26M

-2.07%8.62M

219.62%8.90M

76.05%-6.22M

1526.45%64.66M

430.68%8.80M

-481.86%-7.44M

-709.94%-25.96M

68.15%-4.53M

-90.41%1.66M

-24.30%-1.28M

-92.48%4.26M

-527.16%-14.23M

-73.63%17.30M

89.47%-1.03M

1623.08%56.59M

--3.33M

--65.60M

---9.77M

--3.28M

--0.00

Other non-operating income (expenses)

----

--19.95M

---1.99M

----

--0.00

100.00%0.00

----

--0.00

---49.00K

----

--0.00

Income before tax

2.27%-36.80M

-145.02%-17.62M

-18.45%-24.80M

55.33%-17.51M

33.54%-37.66M

222.71%39.14M

16.59%-20.94M

-50.81%-39.20M

-149.55%-56.66M

13.72%-31.90M

-574.89%-25.11M

-2.82%-26.00M

-161.59%-22.71M

-86.41%-36.97M

-108.74%-3.72M

19.90%-25.28M

314.37%36.87M

2.31%-19.83M

362.68%42.59M

-77.72%-31.56M

---17.20M

---20.30M

---16.21M

---17.76M

Income tax

--0.00

----

Income after tax

2.27%-36.80M

-145.02%-17.62M

-18.45%-24.80M

55.33%-17.51M

33.54%-37.66M

222.71%39.14M

16.59%-20.94M

-50.81%-39.20M

-149.55%-56.66M

13.72%-31.90M

-574.89%-25.11M

-2.82%-26.00M

-161.59%-22.71M

-86.41%-36.97M

-108.74%-3.72M

19.90%-25.28M

314.37%36.87M

2.31%-19.83M

362.68%42.59M

-77.72%-31.56M

---17.20M

---20.30M

---16.21M

---17.76M

Net income from continuous operations

2.27%-36.80M

-145.02%-17.62M

-18.45%-24.80M

55.33%-17.51M

33.54%-37.66M

222.71%39.14M

16.59%-20.94M

-50.81%-39.20M

-149.55%-56.66M

13.72%-31.90M

-574.89%-25.11M

-2.82%-26.00M

-161.59%-22.71M

-86.41%-36.97M

-108.74%-3.72M

19.90%-25.28M

314.37%36.87M

2.31%-19.83M

362.68%42.59M

-77.72%-31.56M

---17.20M

---20.30M

---16.21M

---17.76M

Net income attributable to controlling interests

2.27%-36.80M

-145.02%-17.62M

-18.45%-24.80M

55.33%-17.51M

33.54%-37.66M

222.71%39.14M

16.59%-20.94M

-50.81%-39.20M

-149.55%-56.66M

13.72%-31.90M

-574.89%-25.11M

-2.82%-26.00M

-161.59%-22.71M

-86.41%-36.97M

-108.74%-3.72M

19.90%-25.28M

314.37%36.87M

2.31%-19.83M

362.68%42.59M

-77.72%-31.56M

---17.20M

---20.30M

---16.21M

---17.76M

Net income attributable to common shareholders

2.27%-36.80M

-145.02%-17.62M

-18.45%-24.80M

55.33%-17.51M

33.54%-37.66M

222.71%39.14M

16.59%-20.94M

-50.81%-39.20M

-149.55%-56.66M

13.72%-31.90M

-574.89%-25.11M

-2.82%-26.00M

-161.59%-22.71M

-86.41%-36.97M

-108.74%-3.72M

19.90%-25.28M

314.37%36.87M

2.31%-19.83M

362.68%42.59M

-77.72%-31.56M

---17.20M

---20.30M

---16.21M

---17.76M

Basic earnings per share

35.13%-0.16

-129.92%-0.09

19.57%-0.13

66.31%-0.11

49.05%-0.24

201.01%0.30

31.98%-0.16

-30.65%-0.33

-116.43%-0.48

17.70%-0.29

-571.96%-0.24

-2.41%-0.25

-161.38%-0.22

-85.94%-0.36

-108.72%-0.04

19.93%-0.25

314.36%0.36

2.31%-0.19

362.68%0.41

-77.72%-0.31

---0.17

---0.20

---0.16

---0.17

Diluted earnings per share

35.13%-0.16

-129.98%-0.09

19.57%-0.13

66.31%-0.11

49.05%-0.24

200.81%0.30

31.98%-0.16

-30.65%-0.33

-116.43%-0.48

17.70%-0.29

-571.96%-0.24

-2.41%-0.25

-161.91%-0.22

-85.94%-0.36

-108.72%-0.04

19.93%-0.25

312.50%0.35

2.31%-0.19

362.68%0.41

-77.72%-0.31

---0.17

---0.20

---0.16

---0.17

Dividend per share

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Humacyte Inc's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing HUMA stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Humacyte Inc's revenue at year end?



Humacyte Inc reported 2.04M in revenue for fiscal year 2025, up from 2.04M in the previous year.

How much revenue did Humacyte Inc report in the most recent quarter?



Humacyte Inc reported 406.00K in revenue for the most recent quarter, an increase of 34.88% year over year.

What was Humacyte Inc's net income for the year?



Humacyte Inc posted -40.83M in net income for fiscal year 2025.

How much net income did Humacyte Inc post in the last quarter?



Humacyte Inc reported -36.80M in net income for the latest quarter。

What was Humacyte Inc's annual operating profit?



Humacyte Inc's operating income was -108.14M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.